Eli Lilly and Company reported that its investigational oral GLP-1 receptor agonist, orforglipron, achieved superior oral GLP-1 receptor agonist performance in type 2 diabetes management compared with oral semaglutide in a head-to-head phase 3 trial Furthermore, RPG Life Sciences is sharpening its strategy today with a strong focus on its GLP-1 entry plan and expanding API business, signaling a shift toward high-growth pharmaceutical segments
Can retatrutide be stacked with tirzepatide or semaglutide
Visceral fat is an entirely different beast
Particularly, those who have at least one weight-related ailment or in patients with a BMI of 30 or more

GLPeak goes the distance with you Stability stats, a dose taper overlay, and gentle nudges if you drift NEW: Home Screen Widgets Keep your streak and Daily Targets in sight without opening the app NEW: Works Offline Log shots, weight, and journal entries with no connection Everything syncs automatically when you're back online Health Sync (Health Connect) Sync weight and health data automatically Autofill logs from existing health data for faster tracking Progress Photos & Reports Private before-and-after photos to see changes the scale misses Export clean, shareable progress reports GLP-1 Friendly Recipes Browse recipes suited to smaller appetites and protein goals Streaks & Achievements Build a daily logging streak, earn coins, and unlock achievements Clean, Accessible Design Minimal, modern UI with dark mode and adjustable text sizes GLPEAK+ PREMIUM (PAID UPGRADE) Daily Journal Log mood, energy, habits, symptoms, and reflections Unlimited journal history (free users keep a limited history) Peako AI Unlimited access to Peako, your GLP-1 assistant Ask questions, get tips, and learn to manage GLP-1 challenges Plus the Stats widget, custom app themes, and more
